VIRIDIAN THERAPEUTICS INC. - COMMON STOCK
20,20
22-ноября-24 16:44:58
15 мин. задержка
Акции
+0,58
+2,96%
Сегодняшний диапазон
19,44 - 20,22
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Viridian Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Updates
11 авг 2021 07:00:01 Источник Nasdaq GlobeNewswire
-
Viridian Therapeutics to Participate in the Wedbush PacGrow Healthcare Virtual Conference
05 авг 2021 08:30:00 Источник Nasdaq GlobeNewswire
-
Viridian Therapeutics Appoints Kristian Humer as Chief Financial Officer and Chief Business Officer
26 июл 2021 07:30:00 Источник Nasdaq GlobeNewswire
-
15 июл 2021 16:05:00 Источник Nasdaq GlobeNewswire
-
Viridian Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
14 июл 2021 08:00:01 Источник Nasdaq GlobeNewswire
-
Viridian Therapeutics to Present at the Ladenburg Thalmann 2021 Healthcare Conference
07 июл 2021 08:00:01 Источник Nasdaq GlobeNewswire
-
Viridian Therapeutics to Participate in the JMP Securities Life Sciences Conference
10 июн 2021 08:00:01 Источник Nasdaq GlobeNewswire
-
Viridian Therapeutics to Participate in Upcoming Investor Conferences
14 май 2021 08:00:00 Источник Nasdaq GlobeNewswire
-
Viridian Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Updates
06 май 2021 16:05:01 Источник Nasdaq GlobeNewswire
-
Viridian Therapeutics Reports 2020 Financial Results and Provides Corporate Updates
25 мар 2021 16:05:00 Источник Nasdaq GlobeNewswire
-
09 мар 2021 16:30:00 Источник Nasdaq GlobeNewswire